Selig Zises sold $3.2M of ESQ
director at Esquire Financial Holdings, Inc.. 30,000 shares at an average of $106.30, traded Mar 18, 2026, filed Mar 20, 2026.
Score components
- +15RoleDirector
- +25Trade size$3.2M at market
- +20Share of holdings soldSold 100% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +9.9%, 3m +7.8%, 6m +17.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-26-009212, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 18, 2026 | SOpen-market sale Common Stockindirect: By profit sharing plan | -8,500 | $107.00 | $910k | 12,501 | Mar 20, 2026 |
| Mar 18, 2026 | SOpen-market sale Common Stockindirect: By profit sharing plan | -2,000 | $105.54 | $211k | 10,501 | Mar 20, 2026 |
| Mar 18, 2026 | SOpen-market sale Common Stockindirect: By profit sharing plan | -2,000 | $106.04 | $212k | 8,501 | Mar 20, 2026 |
| Mar 19, 2026 | SOpen-market sale Common Stockindirect: By profit sharing plan | -2,000 | $105.25 | $211k | 6,501 | Mar 20, 2026 |
| Mar 18, 2026 | SOpen-market sale Common Stockindirect: By Trust | -1,500 | $105.11 | $158k | 77,533 | Mar 20, 2026 |
| Mar 18, 2026 | SOpen-market sale Common Stockindirect: By Trust | -2,000 | $105.16 | $210k | 75,533 | Mar 20, 2026 |
| Mar 18, 2026 | SOpen-market sale Common Stockindirect: By Trust | -1,500 | $106.08 | $159k | 74,033 | Mar 20, 2026 |
| Mar 18, 2026 | SOpen-market sale Common Stockindirect: By Trust | -1,500 | $107.01 | $161k | 72,533 | Mar 20, 2026 |
| Mar 18, 2026 | SOpen-market sale Common Stockindirect: By Trust | -2,000 | $107.13 | $214k | 70,533 | Mar 20, 2026 |
| Mar 18, 2026 | SOpen-market sale Common Stockindirect: By Trust | -3,000 | $107.25 | $322k | 67,533 | Mar 20, 2026 |
| Mar 18, 2026 | SOpen-market sale Common Stockindirect: By Trust | -1,000 | $107.26 | $107k | 66,533 | Mar 20, 2026 |
| Mar 19, 2026 | SOpen-market sale Common Stockindirect: By Trust | -3,000 | $105.00 | $315k | 63,533 | Mar 20, 2026 |
Related signals
Other insiders at Esquire Financial Holdings, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | ESQsell Esquire Financial Holdings, Inc. | Andrew C Sagliocca Vice Chairman, President & CEO | $1.2M 10,000 shares | -3% | |
| 31Weak | ESQsell Esquire Financial Holdings, Inc. | Robert Mitzman director | $389k 3,000 shares | -2% | |
| 36Weak | Esquire Financial Holdings, Inc. | Richard T Powers director | $242k 2,308 shares | -4% | |
| 47Moderate | Esquire Financial Holdings, Inc. | Joseph Melohn director | $900k 9,000 shares | -7% | |
| 68Notable | Esquire Financial Holdings, Inc. | Selig Zises director | $1.7M 17,000 shares | -58% | |
| 48Moderate | Esquire Financial Holdings, Inc. | Joseph Melohn director | $1.2M 12,326 shares | -8% | |
| 38Weak | ESQsell Esquire Financial Holdings, Inc. | Selig Zises director | $477k 5,000 shares | -16% | |
| 65Notable | Esquire Financial Holdings, Inc. | Selig Zises director | $1.1M 13,000 shares | -37% | |
| 43Moderate | Esquire Financial Holdings, Inc. | Kevin C Waterhouse director | $252k 3,000 shares | -3% | |
| 60Notable | Esquire Financial Holdings, Inc. | Ari P Kornhaber EVP and Head of Corp Dev | $1.7M 20,000 shares | -16% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.